OBJECTIVE
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have demonstrated cardiorenal benefits in individuals with type 2 diabetes, but safety data in older adults remain limited. We evaluated the real-world safety of SGLT2is compared with dipeptidyl peptidase 4 inhibitors (DPP-4is) among individuals aged ≥75 yea...
Hanin Harbi, Michael Nesrallah, G. Carney et al.· Diabetes Care· 0 citations
MHT use in Canada is increasing but remains modest and variable across formulations and provinces, and Markedly higher use of MHT in Quebec may be partly explained by a more comprehensive drug coverage.
Armin Farahvash, Jessica Riad, Lara Ali et al.· Menopause· 0 citations
Background: In Ontario, Canada, nearly 40% of older adults living in long-term care (LTC) homes have diabetes. Many are managed to intensive glycemic targets counter to current clinical guidelines, which increases residents’ risks for medication-related harm, hypoglycemia, discomfort, and reduced quality of life. Deint...
Kainat Bashir, Wade Thompson, Alexa Muir et al.· International Journal of Int...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.